Image

Published: Aug 24, 2025 | DOI: 10.24911/ejmcr.9-2267

Triple antithrombotic therapy in absence of atrial fibrillation in ACS with high thrombus burden.


Authors: Antonios Samaras , Thrasivoulos Konstantinou , Ioannis Vogiatzis orcid logo ,


Article Info

Authors

Antonios Samaras

Department of Cardiology, General Hospital of Veroia, Veroia, Greece

Thrasivoulos Konstantinou

Department of Cardiology, General Hospital of Veroia, Veroia, Greece

Ioannis Vogiatzis

Department of Cardiology, General Hospital of Veroia, Veroia, Greece

orcid logo ORCID

Publication History

Received: June 20, 2025

Accepted: July 23, 2025

Published: August 24, 2025


Abstract


Patients with atrial fibrillation and ACS need triple antithrombotic therapy (double antiplatelet plus anticoagulant).

In cases of ACS where a high thrombus burden exists, even in the absence of atrial fibrillation, triple antithrombotic therapy (double antiplatelet plus anticoagulant) is essential.


Keywords: PCI, ACS, Triple antithrombotic therapy, Thrombus burden, Thrombus aspiration, IVUS, Deferred stenting